Logo

Inovio Presents Cancer Killing Data of Its Transformative DNA-...

PLYMOUTH MEETING, Pennsylvania, April 2, 2019 /PRNewswire-AsiaNet/ -- -- Data demonstrates tumor-clearing ability of Inovio's dBiTE technology in preclinical cancer modelInovio Pharmaceuticals, Inc. (NASDAQ: INO) announced today the company's novel DNA-Encoded Bi-specific T Cell Engagers (dBiTEs(TM)) generated p...

Authors: LATEST ASIANET NEWS RELEASES

Read more

Asian Spectator by NewsServices.com - office@NewsServices.com - 1300 660 660